Report copyright - Applications cliniques des AcM, la radioimmunothérapie (RIT) · 2011-10-17 · AMM Zevalin ® LF CD20+ traité par chimio-immunothérapie Day Wagner et al.J Nucl Med 2002;43:267–272
Please pass captcha verification before submit form
Please pass captcha verification before submit form